These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

177 related items for PubMed ID: 21159922

  • 1. Persistence of Leishmania donovani antibodies in past visceral leishmaniasis cases in India.
    Gidwani K, Picado A, Ostyn B, Singh SP, Kumar R, Khanal B, Lejon V, Chappuis F, Boelaert M, Sundar S.
    Clin Vaccine Immunol; 2011 Feb; 18(2):346-8. PubMed ID: 21159922
    [Abstract] [Full Text] [Related]

  • 2. Evaluation of direct agglutination test, rk39 Test, and ELISA for the diagnosis of visceral leishmaniasis.
    Mandal J, Khurana S, Dubey ML, Bhatia P, Varma N, Malla N.
    Am J Trop Med Hyg; 2008 Jul; 79(1):76-8. PubMed ID: 18606766
    [Abstract] [Full Text] [Related]

  • 3. Significantly lower anti-Leishmania IgG responses in Sudanese versus Indian visceral leishmaniasis.
    Bhattacharyya T, Bowes DE, El-Safi S, Sundar S, Falconar AK, Singh OP, Kumar R, Ahmed O, Boelaert M, Miles MA.
    PLoS Negl Trop Dis; 2014 Feb; 8(2):e2675. PubMed ID: 24587456
    [Abstract] [Full Text] [Related]

  • 4. rK39 enzyme-linked immunosorbent assay for diagnosis of Leishmania donovani infection.
    Zijlstra EE, Daifalla NS, Kager PA, Khalil EA, El-Hassan AM, Reed SG, Ghalib HW.
    Clin Diagn Lab Immunol; 1998 Sep; 5(5):717-20. PubMed ID: 9729541
    [Abstract] [Full Text] [Related]

  • 5. Latent infection with Leishmania donovani in highly endemic villages in Bihar, India.
    Hasker E, Kansal S, Malaviya P, Gidwani K, Picado A, Singh RP, Chourasia A, Singh AK, Shankar R, Menten J, Wilson ME, Boelaert M, Sundar S.
    PLoS Negl Trop Dis; 2013 Sep; 7(2):e2053. PubMed ID: 23459501
    [Abstract] [Full Text] [Related]

  • 6. Serological markers for leishmania donovani infection in Nepal: Agreement between direct agglutination test and rK39 ELISA.
    Khanal B, Rijal S, Ostyn B, Picado A, Gidwani K, Menten J, Jacquet D, Lejon V, Chappuis F, Boelaert M.
    Trop Med Int Health; 2010 Nov; 15(11):1390-4. PubMed ID: 21998875
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Conversion of asymptomatic infection to symptomatic visceral leishmaniasis: A study of possible immunological markers.
    Das VNR, Bimal S, Siddiqui NA, Kumar A, Pandey K, Sinha SK, Topno RK, Mahentesh V, Singh AK, Lal CS, Singh SK, Das P.
    PLoS Negl Trop Dis; 2020 Jun; 14(6):e0008272. PubMed ID: 32555598
    [Abstract] [Full Text] [Related]

  • 9. Diagnosing visceral leishmaniasis with the recombinant K39 strip test: experience from the Sudan.
    Zijlstra EE, Nur Y, Desjeux P, Khalil EA, El-Hassan AM, Groen J.
    Trop Med Int Health; 2001 Feb; 6(2):108-13. PubMed ID: 11251906
    [Abstract] [Full Text] [Related]

  • 10. rKLO8, a novel Leishmania donovani - derived recombinant immunodominant protein for sensitive detection of visceral leishmaniasis in Sudan.
    Abass E, Bollig N, Reinhard K, Camara B, Mansour D, Visekruna A, Lohoff M, Steinhoff U.
    PLoS Negl Trop Dis; 2013 Feb; 7(7):e2322. PubMed ID: 23875052
    [Abstract] [Full Text] [Related]

  • 11. Strong association between serological status and probability of progression to clinical visceral leishmaniasis in prospective cohort studies in India and Nepal.
    Hasker E, Malaviya P, Gidwani K, Picado A, Ostyn B, Kansal S, Singh RP, Singh OP, Chourasia A, Kumar Singh A, Shankar R, Wilson ME, Khanal B, Rijal S, Boelaert M, Sundar S.
    PLoS Negl Trop Dis; 2014 Feb; 8(1):e2657. PubMed ID: 24466361
    [Abstract] [Full Text] [Related]

  • 12. Determinants for progression from asymptomatic infection to symptomatic visceral leishmaniasis: A cohort study.
    Chakravarty J, Hasker E, Kansal S, Singh OP, Malaviya P, Singh AK, Chourasia A, Singh T, Sudarshan M, Singh AP, Singh B, Singh RP, Ostyn B, Fakiola M, Picado A, Menten J, Blackwell JM, Wilson ME, Sacks D, Boelaert M, Sundar S.
    PLoS Negl Trop Dis; 2019 Mar; 13(3):e0007216. PubMed ID: 30917114
    [Abstract] [Full Text] [Related]

  • 13. Enzyme-linked immunosorbent assay for recombinant K39 antigen in diagnosis and prognosis of Indian visceral leishmaniasis.
    Kumar R, Pai K, Pathak K, Sundar S.
    Clin Diagn Lab Immunol; 2001 Nov; 8(6):1220-4. PubMed ID: 11687466
    [Abstract] [Full Text] [Related]

  • 14. Detection of asymptomatic Leishmania infection in Bangladesh by antibody and antigen diagnostic tools shows an association with post-kala-azar dermal leishmaniasis (PKDL) patients.
    Owen SI, Hossain F, Ghosh P, Chowdhury R, Hossain MS, Jewell C, Cruz I, Picado A, Mondal D, Adams ER.
    Parasit Vectors; 2021 Feb 17; 14(1):111. PubMed ID: 33597000
    [Abstract] [Full Text] [Related]

  • 15. Validation of a β-ME ELISA for detection of anti Leishmania donovani antibodies in Eastern Sudan.
    Abass E, Mahamoud A, Mansour D, Mohebali M, El Harith A.
    Iran J Immunol; 2011 Sep 17; 8(3):150-8. PubMed ID: 21931201
    [Abstract] [Full Text] [Related]

  • 16. Detection of Leishmania donovani in peripheral blood of asymptomatic individuals in contact with patients with visceral leishmaniasis.
    Banu SS, Meyer W, Ahmed BN, Kim R, Lee R.
    Trans R Soc Trop Med Hyg; 2016 May 17; 110(5):286-93. PubMed ID: 27198212
    [Abstract] [Full Text] [Related]

  • 17. A comparison of the direct agglutination test and enzyme-linked immunosorbent assay in the sero-diagnosis of leishmaniasis in the Sudan.
    el Safi SH, Evans DA.
    Trans R Soc Trop Med Hyg; 1989 May 17; 83(3):334-7. PubMed ID: 2617579
    [Abstract] [Full Text] [Related]

  • 18. Immunochromatographic rK39 strip test in the serodiagnosis of visceral leishmaniasis in Tunisia.
    Saghrouni F, Gaïed-Meksi S, Fathallah A, Amri F, Ach H, Guizani I, Ben Saïd M.
    Trans R Soc Trop Med Hyg; 2009 Dec 17; 103(12):1273-8. PubMed ID: 19070876
    [Abstract] [Full Text] [Related]

  • 19. Validation of rK39 immunochromatographic test and direct agglutination test for the diagnosis of Mediterranean visceral leishmaniasis in Spain.
    Bangert M, Flores-Chávez MD, Llanes-Acevedo IP, Arcones C, Chicharro C, García E, Ortega S, Nieto J, Cruz I.
    PLoS Negl Trop Dis; 2018 Mar 17; 12(3):e0006277. PubMed ID: 29494596
    [Abstract] [Full Text] [Related]

  • 20. Pre- and post-treatment antibody levels in visceral leishmaniasis.
    Hailu A.
    Trans R Soc Trop Med Hyg; 1990 Mar 17; 84(5):673-5. PubMed ID: 2278067
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 9.